Erol Ç, Şahin Ö, Kanyılmaz G, Erol S
Department of Nuclear Medicine, Beyhekim Training and Research Hospital, Konya, Turkey.
Department of Nuclear Medicine, Meram Faculty of Medicine, Necmettin Erbakan University, Konya, Turkey.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jun 20:500160. doi: 10.1016/j.remnie.2025.500160.
The aim of our study was to determine whether volumetric parameters measured from the primary lesion and metastatic lymph node (LN) using [F]FDG PET/CT imaging affect prognosis and survival in nasopharyngeal cancer (NPC) patients.
Our study included 62 patients diagnosed with NPC who underwent [F]FDG PET/CT imaging for pre-treatment staging. SUVmax, SUVmean, MTV and TLG values were measured from the primary tumor and LN. Lymph node/primary tumor SUV ratio (NTR) was calculated. The relationships between volumetric parameters and overall survival (OS), locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS) and progression-free survival (PFS) were evaluated.
LN SUVmax and LN SUVmean values were significantly higher in patients with distant metastases (p = 0.002 and p = 0.016, respectively). NTR values were significantly higher in patients with distant metastases (p = 0.047). The ideal LN SUVmax and SUVmean cut-off values for predicting distant metastasis in patients with LN metastasis were 16.45 and 6.5, respectively. There was a statistically significant difference between the DMFSs of the two groups when the NTR cut-off value was 0.8 (p = 0.047). Multivariate analysis showed that LN SUVmax, LN SUVmean and NTR were associated with DMFS (P = 0.003, 0.05 and 0.014, respectively), while primary tumor TLG and MTV values were associated with LRRFS (P = 0.035 and 0.03, respectively).
In conclusion, we believe that LN SUVmax, SUVmean and NTR may be prognostic indicators for distant metastasis, and MTV and TLG for locoregional recurrence.
本研究旨在确定使用[F]FDG PET/CT成像从原发性病变和转移性淋巴结(LN)测量的体积参数是否会影响鼻咽癌(NPC)患者的预后和生存。
我们的研究纳入了62例经诊断患有NPC且接受[F]FDG PET/CT成像进行治疗前分期的患者。从原发性肿瘤和LN测量SUVmax、SUVmean、MTV和TLG值。计算淋巴结/原发性肿瘤SUV比值(NTR)。评估体积参数与总生存期(OS)、局部区域无复发生存期(LRRFS)、远处转移无复发生存期(DMFS)和无进展生存期(PFS)之间的关系。
远处转移患者的LN SUVmax和LN SUVmean值显著更高(分别为p = 0.002和p = 0.016)。远处转移患者的NTR值显著更高(p = 0.047)。预测有LN转移患者远处转移的理想LN SUVmax和SUVmean临界值分别为16.45和6.5。当NTR临界值为0.8时,两组的DMFS之间存在统计学显著差异(p = 0.047)。多变量分析显示,LN SUVmax、LN SUVmean和NTR与DMFS相关(分别为P = 0.003、0.05和0.014),而原发性肿瘤TLG和MTV值与LRRFS相关(分别为P = 0.035和0.03)。
总之,我们认为LN SUVmax、SUVmean和NTR可能是远处转移的预后指标,而MTV和TLG是局部区域复发的预后指标。